Dr. Michelle R. Salvaggio, MD

Dr. Salvaggio practices at Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma.

Dr. Salvaggio's NPI, 1609845437, was assigned on March 15, 2006. Dr. Salvaggio graduated from OU College of Medicine in 1998. Dr. Salvaggio holds Oklahoma license 21268.

Dr. Salvaggio's primary practice is Ou Medical Center-the Children's Ho - Rad CT - HOPD, at 1200 Childrens Ave, Oklahoma City, OK 73104.

Dr. Salvaggio's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dr. Salvaggio is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Salvaggio to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salvaggio practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Salvaggio's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Salvaggio is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Salvaggio's licenses on file in 2 states: Oklahoma and Alabama.

Dmand AI lists acute skin infection, hepatitis c, hiv/aids, joint or bone infection and shingles among the conditions Dr. Salvaggio treats.

CMS data shows 227 Medicare services from Dr. Salvaggio across 6 procedure codes in 2024, for 111 Medicare patients. Medicare paid $16,613 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 111 Medicare patients who saw Dr. Salvaggio in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salvaggio's median patient age at 61, with 40% women.

In 2024, Dr. Salvaggio wrote 2,123 Medicare Part D claims for 115 patients. 58% of them were for generic drugs. CMS names the drug for 1,863 of them, across 55 drugs with 11 or more claims each, at $2,539,346 in total drug cost. In 2023, CMS named 1,337 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Salvaggio for performance year 2024, reported as part of a group. Dr. Salvaggio accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Salvaggio, published from 2007 to 2023. 2014 was the busiest year, with 3. The most frequent topics are Anti-Bacterial Agents, HIV Infections and Oklahoma. Dr. Salvaggio has published most often in J Okla State Med Assoc. Dr. Salvaggio's most frequent co-authors are Michael S. Bronze, MD, Aftab Ahmed, MD and Tauseef Ali, MD.

CMS Open Payments shows 8 general payments to Dr. Salvaggio from 2 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. The Medicines Company paid the most, $165.

Dr. Salvaggio graduated from OU College of Medicine in 1998.

Dr. Salvaggio is in network with 13 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.